Naoki Shingu - Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc, Saiseikai Kumamoto Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab with Etoposide and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer and Interstitial Lung Disease: A Multicenter, Open-Label Prospective Trial

Ryota Shibaki,Daichi Fujimoto,Eisaku Miyauchi,Yoko Tsukita,Ichiro Nakachi,Daisuke Arai,Yoshihiko Sakata,Naoki Shingu,Toshio Shimokawa,Takashi Kijima,Motohiro Tamiya, Sachiko Kawana,Satoshi Harai,Go Saito,Yuki Sato,Toshihide Yokoyama, Shinya Sakata, Yoshihiko Taniguchi,Akito Hata,Hirotaka Matsumoto,Teppei Yamaguchi,Nobuyuki Yamamoto

LUNG CANCER (2024)

引用0浏览0WOS引用

Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study

Yosuke Kakiuchi, Koichi Saruwatari,Kenta Murotani,Takaaki Tokito, Toyohisa Iriki, Jun Iwakawa, Yoshihiko Sakata,Naoki Shingu, Sho Saeki, Megumi Inaba,Akira Takaki, Shunsuke Misono, Takayuki Suetsugu,Koichi Azuma,Keiko Mizuno, Takuro Sakagami

Clinical lung cancer (2024)

引用0浏览0WOS引用

Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer: A Multicenter, Retrospective Study

Yosuke Kakiuchi,Koichi Saruwatari,Kenta Murotani,Takaaki Tokito,Toyohisa Iriki,Jun Iwakawa,Yoshihiko Sakata,Naoki Shingu,Sho Saeki,Megumi Inaba,Akira Takaki,Shunsuke Misono,Takayuki Suetsugu,Koichi Azuma,Keiko Mizuno,Takuro Sakagami

Clinical Lung Cancer (2024)

引用0浏览0引用

Phase II Study of Durvalumab (MEDI 4736) Plus Carboplatin and Etoposide in Elderly Patients with Extensive Stage Small Cell Lung Cancer: Study Protocol of Turtle Study (LOGIK 2003)

Hidenobu Ishii,Koichi Azuma,Takayuki Shimose,Hiroshige Yoshioka,Takayasu Kurata,Naoki Shingu,Masaki Okamoto,Yosuke Kawashima,Isamu Okamoto

Thoracic cancer（2022）

引用1浏览0WOS引用

Clinical Outcomes and Predictive Value of Programmed Cell Death-Ligand 1 Expression in Response to Anti-Programmed Cell Death 1/ligand 1 Antibodies in Non-Small Cell Lung Cancer Patients with Performance Status 2 or Greater

Jodai Takayuki,Saruwatari Koichi,Ikeda Tokunori,Moriyama Eiji,Kashiwabara Kosuke,Shingu Naoki,Iyonaga Kazuhiro,Inaba Megumi,Ajishi Yusuke, Honda Chiharu,Hirosako Susumu,Maruyama Hirotaka,Kakiuchi Yosuke, Eida Hirofumi,Tomita Yusuke,Saeki Sho,Ichiyasu Hidenori,Sakagami Takuro

International journal of clinical oncology（2020）

引用4浏览0WOS引用

Comparisons Between Tumor Burden and Other Prognostic Factors That Influence Survival of Patients with Non‐small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Yoshihiko Sakata,Kodai Kawamura,Kazuya Ichikado,Naoki Shingu,Yuko Yasuda,Yoshitomo Eguchi,Jumpei Hisanaga,Tatsuya Nitawaki,Miwa Iio,Yuko Sekido,Aiko Nakano,Takuro Sakagami

Thoracic Cancer（2019）

引用17浏览0WOS引用

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer with Brain Metastases

Koichi Saruwatari,Tokunori Ikeda,Sho Saeki,Naoki Shingu,Kosuke Imamura, Taiyou Komatu,Sunao Ushijima,Hirotaka Maruyama,Kosuke Kashiwabara,Yusuke Tomita,Hidenori Ichiyasu,Kazuhiko Fujii,Takuro Sakagami

Anticancer Research/Anticancer research（2019）

引用6浏览0WOS引用

The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment

Yoshihiko Sakata,Kodai Kawamura,Kazuya Ichikado,Naoki Shingu,Yuko Yasuda,Yoshitomo Eguchi,Keisuke Anan,Junpei Hisanaga,Tatsuya Nitawaki,Miwa Iio,Yuko Sekido,Aiko Nakano,Takuro Sakagami

Lung Cancer（2019）

引用28浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn